Attenuated Salmonella enterica Serovar Typhi Live Vector with Inducible Chromosomal Expression of the T7 RNA Polymerase and Its Evaluation with Reporter Genes

Barry, 1996, Expression and immunogenicity of pertussis toxin S subunit-tetanus toxin fragment C fusions in Salmonella typhi strain CVD908, Infect. Immun., 64, 4172, 10.1128/IAI.64.10.4172-4181.1996 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Chatfield, 1992, Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine, Biotechnology, 10, 888, 10.1038/nbt0892-888 deHaseth, 1998, RNA polymerase-promoter interactions: The comings and goings of RNA polymerase, J. Bacteriol., 180, 3019, 10.1128/JB.180.12.3019-3025.1998 Galen, 1997, A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed antigens, Vaccine, 15, 700, 10.1016/S0264-410X(96)00227-7 Galen, 1999, Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD908-htrA, Infect. Immun., 67, 6424, 10.1128/IAI.67.12.6424-6433.1999 Gay, 1985, Positive selection procedure for entrapment of insertion sequence elements in Gram-negative bacteria, J. Bacteriol., 164, 918, 10.1128/JB.164.2.918-921.1985 Giron, 1995, Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic E. coli by ΔroC ΔaroD Salmonella typhi vaccine strain CVD908, Vaccine, 13, 939, 10.1016/0264-410X(95)00003-J Gomez-Duarte, 1995, Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphteria toxin in Salmonella typhi CVD908 vaccine strain, Vaccine, 13, 1596, 10.1016/0264-410X(95)00094-H González, 1994, Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum: Strain construction and safety and immunogenicity in humans, J. Infect. Dis., 169, 927, 10.1093/infdis/169.4.927 González, 1998, Immunogenicity of a Salmonella typhi CVD908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana, Vaccine, 16, 1043, 10.1016/S0264-410X(97)00267-3 Heusterspreute, 1985, Vectors with restriction site banks. IV, pJRD184, a 3793-bp plasmid vector having 43 unique cloning sites, Gene, 39, 299, 10.1016/0378-1119(85)90327-0 Hone, 1991, Construction of genetically defined double aro mutants of Salmonella typhi, Vaccine, 9, 810, 10.1016/0264-410X(91)90218-U Hone, 1994, Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine, Dev. Biol. Stand., 82, 159 Kochetkov, 1998, Recent studies of T7 RNA polymerase mechanism, FEBS Lett., 440, 264, 10.1016/S0014-5793(98)01484-7 Lattermann, 1999, Immunogenicity of the extracellular copper/zinc superoxide dismutase of the filarial parasite Acanthochelionema viteae delivered by a two-phase vaccine strain of Salmonella typhimurium, Parasite Immunol., 21, 219, 10.1046/j.1365-3024.1999.00207.x Mertens, 1995, Tight transcriptional control mechanism ensures stable high-level expression from T7 promoter-based expression plasmids, Bio/Technology, 13, 175, 10.1038/nbt0295-175 Oxer, 1991, High level heterologous expression in E. coli using the anaerobically-activated nirB promoter, Nucleic Acids Res., 19, 2889, 10.1093/nar/19.11.2889 Studier, 1986, Use of bacteriophage T7 RNA polymerase to direct the selective high-level expression of cloned genes, J. Mol. Biol., 189, 113, 10.1016/0022-2836(86)90385-2 Sztein, 1994, Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi, J. Infect. Dis., 170, 1508, 10.1093/infdis/170.6.1508 Sztein, 1995, Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans, J. Immunol., 155, 3987, 10.4049/jimmunol.155.8.3987 Tacket, 1997, Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC, aroD and immune response in humans, Infect. Immun., 65, 452, 10.1128/IAI.65.2.452-456.1997 Tacket, 2000, Safety and immune response to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanous toxin fragment C, Clin. Immunol., 97, 143, 10.1006/clim.2000.4924 Tacket, 2000, Phase II clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD908-htrA in U.S. volunteers, Infect. Immun., 68, 1196, 10.1128/IAI.68.3.1196-1201.2000 Wells, 1993, Lactococcus lactis: High-level expression of tetanus toxin fragment C and protection against lethal challenge, Mol. Microbiol., 8, 1155, 10.1111/j.1365-2958.1993.tb01660.x